Delivery Order SPE2DB25D3110-SPE2DB25FTEAT
- Not listed
- The Defense Logistics Agency awarded a $11,425.14 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with completion targeted for July 15, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a $4,190.76 delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical products, with a ceiling value of $2,202.89. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The delivery order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award represents a child delivery order under...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,793.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml pharmaceutical supplies, with an ultimate completion date of July 1, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling through December 2026. The products will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 ml pharmaceutical product with a ceiling value of $5,668.65. This firm fixed price delivery order, with an ultimate completion date of August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract value $999,999,999.00 through December 2026). The award was made...
- The Defense Logistics Agency awarded a $1,806.37 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This is a firm fixed-price, non-set-aside contract with performance completion targeted for September 16, 2025, and fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,047.66 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $1,629.67 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL injectable medication. The contract, which carries no set-aside designation, is scheduled for completion by September 2, 2025, with performance taking place at the vendor's Conshohocken facility. This delivery...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEATDelivery Order
The Defense Logistics Agency awarded a $4,190.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's DLA prime contract vehicle enables the supply of a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. This specific delivery order for Norditropin, a human growth hormone medication, exemplifies the company's ongoing role in fulfilling specialized pharmaceutical needs within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/7/25 |